...
首页> 外文期刊>Biopolymers: Original Research on Biomolecules and Biomolecular Assemblies >CONFORMATIONAL ANALYSIS OF BETA-METHYL-PARA-NITROPHENYLALANINE STEREOISOMERS OF CYCLO[D-PEN(2),D-PEN(5)]ENKEPHALIN BY NMR SPECTROSCOPY AND CONFORMATIONAL ENERGY CALCULATIONS
【24h】

CONFORMATIONAL ANALYSIS OF BETA-METHYL-PARA-NITROPHENYLALANINE STEREOISOMERS OF CYCLO[D-PEN(2),D-PEN(5)]ENKEPHALIN BY NMR SPECTROSCOPY AND CONFORMATIONAL ENERGY CALCULATIONS

机译:环戊烯[D-PEN(2),D-PEN(5)]脑啡肽的β-甲基-对位-硝基苯丙氨酸立体异构体的核磁共振波谱和构象能分析

获取原文
获取原文并翻译 | 示例
           

摘要

Solution conformations of beta-methyl-para-nitrophenylalanine(4) analogues of the potent delta-opioid peptide cyclo[D-Pen(2), D-Pen(5)]enkephalin (DPDPE) were studied by combined use of nmr and conformational energy calculations. Nuclear Overhauser effect connectivities and (3)J(HNC alpha H) coupling constants measured for the (2S, 3S)-, (2S, 3R)-, and (2R, 3R)-stereoisomers of [beta-Me-p-NO(2)Phe(4)] DPDPE in DMSO were compared with low energy conformers obtained by energy minimization in the Empirical Conformational Energy Program for Peptides (ECEPP/2) force field. The conformers that satisfied all available nmr data were selected as probable solution conformations of these peptides. Side-chain rotamer populations, established using homonuclear ((3)J(H alpha H beta)) and heteronuclear ((3)J(H alpha C gamma)) coupling constants and C-13 chemical shifts, show that the beta-methyl substituent eliminates one of the three staggered rotamers of the torsion angle chi(1) for each stereoisomer of the beta-Me-p-NO(2)Phe(4). Similar solution conformations were suggested for the L-Phe(4)-containing (2S, 3S)- and (2S, SR)-stereoisomers. Despite some local differences, solution conformations of L- and D-Phe(4)-containing analogues have a common shape of the peptide backbone and allow similar orientations of the main delta-opioid pharmacophores. This type of structure differs from several models of the solution conformations of DPDPE, and from the model of biologically active conformations of DPDPE suggested earlier. The latter model is allowed for the potent (2S, 3S)- and (2S, 3R)-stereoisomers of [beta-Me-p-NO(2)Phe(4)] DPDPE, but it is forbidden for the less active (2R, 3R)- and (2R, 3S)-stereoisomers. It was concluded that the biologically active stereoisomers of [beta-Me-p-NO(2)Phe(4)] DPDPE in the delta-receptor-bound state may assume a conformation different from their favorable conformations in DMSO. (C) 1996 John Wiley & Sons, Inc. [References: 49]
机译:有效的delta-阿片肽环[D-Pen(2),D-Pen(5)]脑啡肽(DPDPE)的β-甲基-对-硝基苯丙氨酸(4)类似物的溶液构象是通过结合使用核磁共振和构象研究的能量计算。 [β-Me-p-NO的(2S,3S)-,(2S,3R)-和(2R,3R)-立体异构体的核Overhauser效应连通性和(3)J(HNCαH)耦合常数(2)Phe(4)]将DMSO中的DPDPE与通过“肽的经验构象能量程序”(ECEPP / 2)力场中的能量最小化获得的低能量构象体进行了比较。选择满足所有可用nmr数据的构象体作为这些肽的可能溶液构象。使用同核((3)J(H alpha H beta))和异核((3)J(H alpha C gamma))耦合常数和C-13化学位移建立的侧链旋转异构体种群显示,β-甲基对于β-Me-p-NO(2)Phe(4)的每个立体异构体,取代基消除了扭转角chi(1)的三个交错旋转异构体之一。对于包含L-Phe(4)的(2S,3S)-和(2S,SR)-立体异构体,提出了类似的溶液构象。尽管存在一些局部差异,但含有L-和D-Phe(4)的类似物的溶液构象具有肽骨架的通用形状,并允许主要的δ-阿片类药效团具有相似的取向。这种类型的结构不同于DPDPE溶液构象的几种模型,也不同于先前提出的DPDPE的生物活性构象的模型。后一种模型允许用于[beta-Me-p-NO(2)Phe(4)] DPDPE的有效(2S,3S)-和(2S,3R)-立体异构体,但对于活性较低的( 2R,3R)-和(2R,3S)-立体异构体。结论是,β-Me-p-NO(2)Phe(4)] DPDPE的生物活性立体异构体在与受体结合的状态下可能具有不同于其在DMSO中有利构象的构象。 (C)1996 John Wiley&Sons,Inc. [参考:49]

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号